ENTRY       D00769                      Drug
NAME        Clopidogrel bisulfate (USP);
            Clopidogrel sulfate (JP18);
            Clopidogrel sulfate tablets (JP18);
            Clopidogrel hydrogen sulphate;
            Isocover (TN);
            Plavix (TN)
PRODUCT     PLAVIX (sanofi-aventis U.S. LLC)
  GENERIC   CLOPIDOGREL (A-S Medication Solutions)
            CLOPIDOGREL (A-S Medication Solutions)
            CLOPIDOGREL (A-S Medication Solutions)
            CLOPIDOGREL (A-S Medication Solutions)
            CLOPIDOGREL (A-S Medication Solutions)
            CLOPIDOGREL (A-S Medication Solutions)
            CLOPIDOGREL (A-S Medication Solutions)
            CLOPIDOGREL (A-S Medication Solutions)
            CLOPIDOGREL (A-S Medication Solutions)
            CLOPIDOGREL (Accord Healthcare)
            CLOPIDOGREL (American Health Packaging)
            CLOPIDOGREL (Amneal Pharmaceuticals LLC)
            CLOPIDOGREL (Aphena Pharma Solutions - Tennessee)
            CLOPIDOGREL (Apotex Corp.)
            CLOPIDOGREL (Aurobindo Pharma Limited)
            CLOPIDOGREL (AvPAK)
            CLOPIDOGREL (Bryant Ranch Prepack)
            CLOPIDOGREL (Bryant Ranch Prepack)
            CLOPIDOGREL (Bryant Ranch Prepack)
            CLOPIDOGREL (Camber Pharmaceuticals)
            CLOPIDOGREL (Clinical Solutions Wholesale)
            CLOPIDOGREL (DIRECT RX)
            CLOPIDOGREL (Direct_Rx)
            CLOPIDOGREL (Golden State Medical Supply)
            CLOPIDOGREL (Legacy Pharmaceutical Packaging)
            CLOPIDOGREL (Macleods Pharmaceuticals Limited)
            CLOPIDOGREL (Major Pharmaceuticals)
            CLOPIDOGREL (NCS HealthCare of KY)
            CLOPIDOGREL (NorthStar RxLLC)
            CLOPIDOGREL (NuCare Pharmaceuticals)
            CLOPIDOGREL (NuCare Pharmaceuticals)
            CLOPIDOGREL (POLYGEN PHARMACEUTICALS)
            CLOPIDOGREL (Preferred Pharmaceuticals)
            CLOPIDOGREL (Proficient Rx LP)
            CLOPIDOGREL (Proficient Rx LP)
            CLOPIDOGREL (REMEDYREPACK)
            CLOPIDOGREL (REMEDYREPACK)
            CLOPIDOGREL (REMEDYREPACK)
            CLOPIDOGREL (REMEDYREPACK)
            CLOPIDOGREL (RPK Pharmaceuticals)
            CLOPIDOGREL (Redpharm Drug)
            CLOPIDOGREL (Rising Pharmaceuticals)
            CLOPIDOGREL (Teva Pharmaceuticals USA)
            CLOPIDOGREL (Vensun Pharmaceuticals)
            CLOPIDOGREL (Viona Pharmaceuticals)
            CLOPIDOGREL (Westminster Pharmaceuticals)
            CLOPIDOGREL (Zydus Lifesciences Limited)
            CLOPIDOGREL BISULFATE (ACI Healthcare USA)
            CLOPIDOGREL BISULFATE (Bryant Ranch Prepack)
            CLOPIDOGREL BISULFATE (Bryant Ranch Prepack)
            CLOPIDOGREL BISULFATE (Bryant Ranch Prepack)
            CLOPIDOGREL BISULFATE (Cardinal Health 107)
            CLOPIDOGREL BISULFATE (Dr.Reddy's Laboratories Limited)
            CLOPIDOGREL BISULFATE (Dr.Reddy's Laboratories Limited)
            CLOPIDOGREL BISULFATE (Graviti Pharmaceuticals Private Limited)
            CLOPIDOGREL BISULFATE (Major Pharmaceuticals)
            CLOPIDOGREL BISULFATE (McKesson Corporation dba SKY Packaging)
            CLOPIDOGREL BISULFATE (NuCare Pharmaceuticals)
            CLOPIDOGREL BISULFATE (PD-Rx Pharmaceuticals)
            CLOPIDOGREL BISULFATE (Preferred Pharmaceuticals)
            CLOPIDOGREL BISULFATE (Proficient Rx LP)
            CLOPIDOGREL BISULFATE (Quallent Pharmaceuticals Health LLC)
            CLOPIDOGREL BISULFATE (RADHA PHARMACEUTICALS)
            CLOPIDOGREL BISULFATE (ScieGen Pharmaceuticals)
            CLOPIDOGREL BISULFATE (Sun Pharmaceutical Industries)
            CLOPIDOGREL BISULFATE (Torrent Pharmaceuticals Limited)
FORMULA     C16H16ClNO2S. H2SO4
EXACT_MASS  419.0264
MOL_WEIGHT  419.9002
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
               DG01808  Thienopyridine
             DG01809  P2Y12 receptor antagonist
              DG01808  Thienopyridine
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG02919  CYP2B6 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01641  CYP2C8 inhibitor
REMARK      Therapeutic category: 3399
            ATC code: B01AC04
            Chemical structure group: DG00155
            Product (DG00155): D00769<JP/US>
            Product (mixture): D10513<JP>
EFFICACY    Anticoagulant, Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist
  DISEASE   Myocardial infarction [DS:H01730]
COMMENT     Thienopyridine derivative
            CYP2C19 poor metabolizer status is associated with diminished response to Clopidogrel.
TARGET      P2RY12 [HSA:64805] [KO:K04298]
  PATHWAY   hsa04611(64805)  Platelet activation
METABOLISM  Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2B6 [HSA:1555]
INTERACTION CYP inhibition: CYP2C8 [HSA:1558]
STR_MAP     map07049  Antithrombosis agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC04 Clopidogrel
                  D00769  Clopidogrel bisulfate (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Platelet Modifying Agents
               Adenosine Diphosphate P2Y12 Inhibitors
                Clopidogrel
                 D00769  Clopidogrel bisulfate (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               339  Miscellaneous
                3399  Others
                 D00769  Clopidogrel bisulfate (USP); Clopidogrel sulfate (JP18); Clopidogrel sulfate tablets (JP18)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG01808  Thienopyridine
                 DG00155  Clopidogrel
                  D00769  Clopidogrel bisulfate
              DG01809  P2Y12 receptor antagonist
               DG01808  Thienopyridine
                DG00155  Clopidogrel
                 D00769  Clopidogrel bisulfate
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00155  Clopidogrel
                D00769  Clopidogrel bisulfate
              DG02919  CYP2B6 substrate
               DG00155  Clopidogrel
                D00769  Clopidogrel bisulfate
              DG01639  CYP2C19 substrate
               DG00155  Clopidogrel
                D00769  Clopidogrel bisulfate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00155  Clopidogrel
                 D00769  Clopidogrel bisulfate
             Metabolizing enzyme inhibitor
              DG01641  CYP2C8 inhibitor
               DG00155  Clopidogrel
                D00769  Clopidogrel bisulfate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Purine / pyrimidine
                P2RY12
                 D00769  Clopidogrel bisulfate (USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00769  Clopidogrel sulfate
              D00769  Clopidogrel sulfate tablets
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00769
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00769
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00769
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00769
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG01808  Thienopyridine
                 DG00155  Clopidogrel
              DG01809  P2Y12 receptor antagonist
               DG01808  Thienopyridine
                DG00155  Clopidogrel
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00155  Clopidogrel
              DG02919  CYP2B6 substrate
               DG00155  Clopidogrel
              DG01639  CYP2C19 substrate
               DG00155  Clopidogrel
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00155  Clopidogrel
             Metabolizing enzyme inhibitor
              DG01641  CYP2C8 inhibitor
               DG00155  Clopidogrel
DBLINKS     CAS: 120202-66-6
            PubChem: 7847834
            ChEBI: 3759
            LigandBox: D00769
ATOM        26
            1   N1y N    21.9223  -14.0768
            2   C1c C    20.7116  -14.7786
            3   C1x C    23.1271  -14.7786
            4   C1x C    21.9164  -12.6791
            5   C8y C    19.5011  -14.0768
            6   C7a C    20.7116  -16.1766
            7   C8y C    24.3378  -14.0827
            8   C1x C    23.1271  -11.9773
            9   C8y C    19.5011  -12.6791
            10  C8x C    18.2904  -14.7786
            11  O7a O    19.5011  -16.8782
            12  O6a O    21.9223  -16.8725
            13  C8y C    24.3378  -12.6791
            14  C8x C    25.6771  -14.5154
            15  C8x C    18.2904  -11.9773
            16  X   Cl   20.7116  -11.9773
            17  C8x C    17.0797  -14.0768
            18  C1a C    18.2904  -16.1766
            19  S2x S    25.6712  -12.2405
            20  C8x C    26.5018  -13.3751
            21  C8x C    17.0797  -12.6791
            22  S4a S    29.6520  -14.3900
            23  O1d O    29.6520  -12.9900
            24  O1d O    29.6520  -15.7900
            25  O1d O    28.2519  -14.3900
            26  O1d O    31.0519  -14.3900
BOND        27
            1     2   5 1
            2     2   6 1 #Down
            3     3   7 1
            4     4   8 1
            5     5   9 1
            6     5  10 2
            7     6  11 1
            8     6  12 2
            9     7  13 2
            10    7  14 1
            11    9  15 2
            12    9  16 1
            13   10  17 1
            14   11  18 1
            15   13  19 1
            16   14  20 2
            17   15  21 1
            18    8  13 1
            19   17  21 2
            20   19  20 1
            21    1   2 1
            22    1   3 1
            23    1   4 1
            24   22  23 2
            25   22  24 2
            26   22  25 1
            27   22  26 1
///
